ProfileGDS4718 / 211922_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 85% 81% 77% 74% 82% 79% 85% 77% 80% 82% 73% 84% 81% 79% 82% 88% 83% 79% 74% 82% 81% 86% 84% 75% 83% 78% 79% 86% 74% 72% 79% 81% 83% 85% 79% 73% 81% 86% 84% 92% 82% 84% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.2006783
GSM549102patient 115, normal, homogenized [OPG study]8.4568785
GSM549104patient 119, normal, homogenized [OPG study]8.0199181
GSM549108patient 138, normal, homogenized [OPG study]7.4721477
GSM549119patient 077, normal, homogenized [OPG study]7.1711374
GSM549133patient 032, cancer, homogenized [OPG study]8.2347582
GSM549139patient 042, cancer, homogenized [OPG study]7.8103879
GSM549099patient 107, normal, homogenized [OPG study]8.3459685
GSM549109patient 139, normal, homogenized [OPG study]7.4384677
GSM549110patient 046, normal, homogenized [OPG study]7.8195180
GSM549114patient 063, normal, homogenized [OPG study]8.1509682
GSM549122patient 082, normal, homogenized [OPG study]7.1574973
GSM549134patient 033, cancer, homogenized [OPG study]8.3704684
GSM549136patient 036, cancer, homogenized [OPG study]8.0847981
GSM549140patient 044, cancer, homogenized [OPG study]7.8813579
GSM549111patient 047, normal, homogenized [OPG study]8.1214382
GSM549113patient 057, normal, homogenized [OPG study]9.1165488
GSM549132patient 031, cancer, homogenized [OPG study]8.2142783
GSM549137patient 038, cancer, homogenized [OPG study]7.7496479
GSM549142patient 047, cancer, homogenized [OPG study]7.1260774
GSM549100patient 110, normal, homogenized [OPG study]8.0434982
GSM549107patient 135, normal, homogenized [OPG study]7.9690881
GSM549115patient 068, normal, homogenized [OPG study]8.7161686
GSM549116patient 072, normal, homogenized [OPG study]8.3834484
GSM549120patient 078, normal, homogenized [OPG study]7.3670575
GSM549131patient 030, cancer, homogenized [OPG study]8.3237883
GSM549118patient 074, normal, homogenized [OPG study]7.6258378
GSM549129patient 027, cancer, homogenized [OPG study]7.8288179
GSM549123patient 088, normal, homogenized [OPG study]8.5933986
GSM549124patient 006, cancer, homogenized [OPG study]7.184274
GSM549126patient 015, cancer, homogenized [OPG study]7.0760572
GSM549128patient 025, cancer, homogenized [OPG study]7.8548679
GSM549103patient 117, normal, homogenized [OPG study]7.8805181
GSM549117patient 073, normal, homogenized [OPG study]8.3150983
GSM549138patient 041, cancer, homogenized [OPG study]8.4969585
GSM549141patient 045, cancer, homogenized [OPG study]7.9075979
GSM549130patient 028, cancer, homogenized [OPG study]7.1672273
GSM549101patient 111, normal, homogenized [OPG study]7.9723981
GSM549105patient 128, normal, homogenized [OPG study]8.5249886
GSM549106patient 134, normal, homogenized [OPG study]8.5130184
GSM549112patient 048, normal, homogenized [OPG study]9.7100792
GSM549125patient 011, cancer, homogenized [OPG study]8.021482
GSM549127patient 024, cancer, homogenized [OPG study]8.2939984
GSM549135patient 035, cancer, homogenized [OPG study]7.867779